Terazosin

Common brands: Terazosin, Tezruly, Aspirin 325, Aspirin 81, Ecotrin

Top reporter: Jubilant Cadista Pharmaceuticals Inc.

Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]HMG-CoA Reductase Inhibitor [EPC]Loop Diuretic [EPC]Corticosteroid [EPC]
8,752
Total Reports
2,586
Serious Reports
946
Death Reports
30
Reported Reactions
Death Report Ratio: High (10.81%)

Patient Demographics

Male
6,899
Female
1,240

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Terazosin.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 541
5.8%
2 FATIGUE 536
5.7%
3 DYSPNOEA 495
5.3%
4 DIARRHOEA 455
4.9%
5 DIZZINESS 451
4.8%
6 ASTHENIA 410
4.4%
7 DEATH 382
4.1%
8 OFF LABEL USE 359
3.8%
9 ACUTE KIDNEY INJURY 357
3.8%
10 FALL 345
3.7%
11 NAUSEA 340
3.6%
12 CHRONIC KIDNEY DISEASE 332
3.5%
13 RENAL FAILURE 330
3.5%
14 PAIN 322
3.4%
15 PNEUMONIA 315
3.4%
16 HYPOTENSION 300
3.2%
17 HEADACHE 296
3.2%
18 CONSTIPATION 245
2.6%
19 MALAISE 241
2.6%
20 WEIGHT DECREASED 234
2.5%
21 BLOOD PRESSURE INCREASED 227
2.4%
22 RASH 223
2.4%
23 ARTHRALGIA 222
2.4%
24 HYPERTENSION 219
2.3%
25 PAIN IN EXTREMITY 218
2.3%
26 COUGH 213
2.3%
27 DECREASED APPETITE 201
2.1%
28 VOMITING 190
2.0%
29 ANAEMIA 189
2.0%
30 PRURITUS 182
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.